Facial Emotion Processing and GABAergic Modulation in Individuals at Clinical High-Risk for Psychosis
Deficits in social cognition, including facial emotion recognition (FER), are present in individuals at clinical high-risk for psychosis (CHR-P). Altered GABAergic and glutamatergic signalling within corticolimbic circuitry has been proposed to underlie FER deficits in psychosis. We investigated FER performance and brain activation in CHR-P individuals, and whether pharmacological enhancement of GABAergic signalling with diazepam modulates these processes. In Study 1, 24 antipsychotic-naive CHR-P individuals and 24 healthy controls underwent fMRI while performing the Penn Emotion Recognition Task. In Study 2, 24 antipsychotic-naive CHR-P individuals participated in a randomised, double-blind, placebo-controlled, crossover study of 5mg diazepam versus placebo. Threat-related FER performance and neural activation were compared between groups and drug conditions. In Study 1, CHR-P individuals showed longer reaction times across emotions (n=22 vs n=23, p=0.01) and greater amygdala (pFWE=0.01) and hippocampal (pFWE=0.04) activation for neutral>fixation. Lower amygdala activation for threat>neutral (pFWE=0.03) and non-threat>neutral (pFWE=0.01), and lower hippocampal activation for non-threat>neutral (pFWE=0.04) may reflect this elevated response to neutral faces. Follow-up analyses showed lower insula (pFWE=0.01) and medial prefrontal cortex activation (pFWE=0.02) for threat>fixation. In Study 2, no significant drug effect on sensitivity was observed in the full sample (n=23), although secondary reduced-sample analyses, excluding one participant identified as influential, suggested improved overall sensitivity under diazepam (n=22; p=0.0499). After adjusting for global cerebral blood flow, diazepam reduced midcingulate cortex activation during neutral>fixation (pFWE=0.04). These findings highlight altered neural processing of neutral expressions in individuals at CHR-P, and suggest that aspects of emotion processing may be sensitive to GABAergic modulation.
Authors
- Philip McGuire
- Maria Antonietta Nettis (ORCID: https://orcid.org/0000-0002-5401-8391)
- Nicholas R Livingston (ORCID: https://orcid.org/0000-0002-6582-2545)
- James Davies (ORCID: https://orcid.org/0000-0002-4177-8842)
- Mitul Ashok Mehta (ORCID: https://orcid.org/0000-0003-1152-5323)
- Thomas James Reilly (ORCID: https://orcid.org/0000-0001-6890-918X)
- Cecilia Casetta (ORCID: https://orcid.org/0000-0002-1980-3415)
- Natasha Vorontsova (ORCID: https://orcid.org/0009-0003-2477-4094)
- Amanda Kiemes (ORCID: https://orcid.org/0000-0001-6819-8090)
- Paulina B. Lukow (ORCID: https://orcid.org/0000-0002-6796-9102)
- Matthew B. Wall (ORCID: https://orcid.org/0000-0002-0493-6274)
- Thomas J. Spencer (ORCID: https://orcid.org/0000-0001-5661-3293)
- Anthony Grace (ORCID: https://orcid.org/0000-0003-1864-5504)
- Aikaterini Dima (ORCID: https://orcid.org/0000-0002-6371-775X)
- Nikita Julius (ORCID: https://orcid.org/0009-0000-0815-0351)
- Maria-Mihaela Avram (ORCID: https://orcid.org/0009-0009-1215-2355)
- Andrea; id_orcid 0000-0002-8358-5715 De Micheli
- Edward Chesney
- Kosha Ruparel
- Owen O’Daly
- Federico Turkheimer
- Samuel R. Knight
- Fernando Zelaya
- Ruben C Gur
- Peter CT Hawkins
- Luke Jelen
- Steven CR Williams
- Paolo Fusar-Poli
- Gemma Modinos
Institutions
- King's College London (GB)
- Perceptive Engineering (United Kingdom) (GB)
- University College London (GB)
- Imperial College London (GB)
- University of Pennsylvania (US)
Publication Details
- Journal
- medRxiv
- Published
- 2026-11-16
- DOI
- https://doi.org/10.64898/2026.11.12.26367443
- Primary Topic
- Schizophrenia research and treatment
- Type
- preprint